Gene · 1673
Papers4,248
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
221 to 240 of 4,248
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| The Role of Bifidobacterium in Liver Diseases: A Systematic Review of Next-Generation Sequencing Studies. | Microorganisms | 2023 | 38138143 | PubTator, text mining | PubMed |
| Super-enhancers and the super-enhancer reader BRD4: tumorigenic factors and therapeutic targets. | Cell Death Discov | 2023 | 38135679 | PubTator, text mining | PubMed |
| Gastroprotective Effects of Oral Glycosaminoglycans with Sodium Alginate in an Indomethacin-Induced Gastric Injury Model in Rats. | Vet Sci | 2023 | 38133218 | PubTator, text mining | PubMed |
| Unraveling Transcriptome Profile, Epigenetic Dynamics, and Morphological Changes in Psoriasis-like Keratinocytes: "Insights into Similarity with Psoriatic Lesional Epidermis". | Cells | 2023 | 38132145 | PubTator, text mining | PubMed |
| Research progress on the relationship between Paneth cells-susceptibility genes, intestinal microecology and inflammatory bowel disease. | World J Clin Cases | 2023 | 38130785 | PubTator, text mining | PubMed |
| DAMPs and alarmin gene expression patterns in aging healthy and diseased mucosal tissues. | Front Oral Health | 2023 | 38098978 | PubTator, text mining | PubMed |
| Functioning and mechanisms of PTMs in renal diseases. | Front Pharmacol | 2023 | 38074159 | PubTator, text mining | PubMed |
| Transcriptomic Analysis of Hidradenitis Suppurativa: A Unique Molecular Signature with Broad Immune Activation. | Int J Mol Sci | 2023 | 38069342 | PubTator, text mining | PubMed |
| Application Value of Antimicrobial Peptides in Gastrointestinal Tumors. | Int J Mol Sci | 2023 | 38069041 | PubTator, text mining | PubMed |
| Epidermal keratinocyte-specific STAT3 deficiency aggravated atopic dermatitis-like skin inflammation in mice through TSLP upregulation. | Front Immunol | 2023 | 38053996 | PubTator, text mining | PubMed |
| Prediction of disease recurrence or residual disease after primary endoscopic resection of pT1 colorectal cancer-results from a large nationwide Danish study. | Int J Colorectal Dis | 2023 | 38036699 | PubTator, text mining | PubMed |
| Integration of signaling pathway and bromodomain and extra-terminal domain inhibition for the treatment of mutant Kirsten rat sarcoma viral oncogene homolog cancer. | Explor Target Antitumor Ther | 2023 | 38023987 | PubTator, text mining | PubMed |
| Anti-Arrhenius behavior of electron transfer reactions in molecular dimers. | Chem Sci | 2023 | 38023507 | PubTator, text mining | PubMed |
| Crosstalk: keratinocytes and immune cells in psoriasis. | Front Immunol | 2023 | 38022549 | PubTator, text mining | PubMed |
| A novel sophorolipids extraction method by yeast fermentation process for enhanced skin efficacy. | Skin Res Technol | 2023 | 38009026 | PubTator, text mining | PubMed |
| Signaling pathways and targeted therapies for psoriasis. | Signal Transduct Target Ther | 2023 | 38008779 | PubTator, text mining | PubMed |
| Biopolymer- and Natural Fiber-Based Biomimetic Tissues to Realize Smart Cosmeceuticals and Nutraceuticals Using an Innovative Approach. | Pharmaceutics | 2023 | 38004505 | PubTator, text mining | PubMed |
| Sea Cucumber Peptides Ameliorate DSS-Induced Ulcerative Colitis: The Role of the Gut Microbiota, the Intestinal Barrier, and Macrophage Polarization. | Nutrients | 2023 | 38004208 | PubTator, text mining | PubMed |
| Targeting Epigenetic Regulators with HDAC and BET Inhibitors to Modulate Muscle Wasting. | Int J Mol Sci | 2023 | 38003594 | PubTator, text mining | PubMed |
| Non-Invasive Assessment of Skin Surface Proteins of Psoriasis Vulgaris Patients in Response to Biological Therapy. | Int J Mol Sci | 2023 | 38003437 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/1673/papers?page=12